1/85
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced | Call with Kai |
|---|
No study sessions yet.
How does reviewing the genetic makeup of a client help guide the PMHNP in selecting medication for clients?
Genetic testing can assist by providing more information on how clients may respond to certain psychotropic medications, as well as providing information on how a client may break down and metabolize medications based on the cytochrome P450 system.
There may be an environmental exposure that turned a gene "on" that should have been "off" for one twin to develop schizophrenia and not the other
. Both environmental and psychosocial stressors can impact mental health. Although twins may have identical genes, their gene expression may be different.
Neuroscience
is the study of the structure and function of the brain and is a field which is making great advancements (Pliszka, 2016). A strong foundational understanding of neuroscience and how the structure and function of the brain can result in mental health symptoms is necessary to treat mental illnesses.
Some mental disorders such as Alzheimer's disease, schizophrenia, and major depressive disorder are thought to be a result of malformations or malfunctions within the brain.
The psychiatric mental health nurse practitioner (PMHNP) must comprehend how medications impact the brain in order to safely and effectively prescribe psychotropic medications.
Brain tissue
is composed of gray and white matter.
gray matter
The cerebellum, cerebrum, brain stem, and the butterfly-shaped portion of the central spinal cord are comprised of gray matter which contains neural cell bodies, axon terminals, dendrites, and all nerve synapses.
It is the working area of the brain and the focus of psychiatry and neurology.
Gray matter
associated with learning.
Changes in the gray matter are linked to psychiatric diagnoses including Alzheimer's disease, schizophrenia, and major depressive disorder.
White Matter
contains nerve fibers that connect neurons from different regions into functional circuits.
The myelin that coats neuronal axons is necessary for electrical impulse transmission.
Think of the white matter as a transit system. If there are breaks in the system, then people cannot get to their destinations.
Within the brain, these breaks affect neural communication, affecting behavior.
Damage to the myelin can impair transmission which can impact not only sensory and motor function, but also cognition.
White matter abnormalities are associated with autism and vascular dementia.
The central sulcus separates which lobes?
frontal lobe from parietal lobe
Frontal lobe
Associated with movement, intelligence, abstract thinking. etc.
Broca's area
Speech
Temporal lobe
Involves object identification and auditory signals
Cerebellum
coordination and balance
Wernicke's area
Speech comprehension
occipital lobe
Primary visual area
parietal lobe
Keeps us alert to what is going on around us
Sensory Cortex
Pain, heat, and other sensations
motor cortex
Movement
Hippocampus
Involved in both memory and anxiety
Nucleus accumbens
Involved in the reward process.
Thalamus
Involved in sensory organ and motor command processing
Striatum
Involved in complex motor actions, also links cognition to motor actions
Limbic System
This includes circuits that are associated with pleasure and reward, emotion and learning
Basal ganglia
A group of structures involved in voluntary motor movements
Amygdala
Involved in emotional regulation and perception of odors
Corpus callosum
Controls the communication between the two brain hemispheres
white matter
Contains nerve fibers that connect neurons from different regions into functional circuits
Grey matter
Contains nerve cells and dendrites
Brain tissue
Made up of grey matter and white matter
What is the global burden of disease of mental health, neurological, and substance use disorders?
30%
How many children and adolescents are impacted by mental health disorders worldwide?
20%
How much does lost productivity related to anxiety and depression cost the global economy each
$1 trillion USD
The development of mental health conditions are linked to causes
such as genetics, biochemical processes, environment, and lifestyle. Mental illness is common, and treatment often includes the use of psychotropic medications.
When prescribing medications, the psychiatric mental health nurse practitioner (PMHNP) must consider each client's unique circumstances including, but not limited to their:
symptoms
age
physical health
previous response to treatment
lifestyle
Treatment for mental health conditions requires
individualized care that incorporates the client's desires and goals.
Which is the priority data used to determine a treatment plan for mental health disorders?
client symptoms
Adherence
can be defined as persistence or compliance.
Persistence is taking the medication over the intended time period.
Compliance is taking the medication as prescribed. According to Dell'Osso et al. (2020), client, clinician, and structural factors all contribute to non-adherence.
Client factors that contribute to nonadherence include
concern about
side effects,
fear of addiction to medications,
misunderstanding of expected outcomes.
Clinician factors that contribute to nonadherence include
lack of shared-decision making with the client, providing inadequate education about medications, and lack of follow up.
Structural factors that contribute to nonadherence include
medication access, medication cost, and stigma associated with mental illness.
Informed Consent
Clients have the right to receive enough information to make decisions about treatment.
They must also be informed about potential risks associated with medications.
Clients have the right to refuse treatment and cannot be forcibly medicated in non-emergencies.
However, clients can be forcibly medicated if they are violent toward themselves or others and when less restrictive methods have failed.
Compliance
A court order may be issued for a client to receive treatment against their wishes if they are considered a danger to themselves or others.
Examples include clients with schizophrenia or sex offenders. Guardians can also provide consent for clients who have limited cognitive capabilities or are incompetent to make decisions.
Ultimately, PMHNPs are responsible for being knowledgeable about their state laws and abiding by them.
Off-Label Perscribing
Some clients may benefit from the unapproved use of a drug for symptom management. For example, many selective serotonin reuptake inhibitors (SSRIs) are used to treat anxiety and obsessive-compulsive disorder but are not FDA approved for use in this disorder.
Off-label prescribing potentially raises ethical and legal concerns; the PMHNP must remain up to date with the latest recommendations for off-label prescribing.
What should the PMHNP consider when prescribing chemical restraints for this client?
Prescribing considerations include carefully reviewing the client's allergy status and prior medication history for adverse drug reactions related to the medications ordered in the chemical restraint.
If the client has a known allergy and was given the medication, the prescriber and staff could be held liable for harm to the client. Also, state regulations regarding chemical restraints must be reviewed, as some states do not allow court-ordered treatment against a client's wishes.
Are the PMHNP and other staff liable if the client has an allergic reaction or adverse side effects to the drugs used for chemical restraint?
No. The client has been court-ordered to take the prescribed medications and the standing order for chemical restraints is approved. The PMHNP and other staff are not liable if the patient has an allergic reaction or adverse side effects.
Normal and abnormal genes both contribute to
disease and drug efficacy.
Epigenetics
can contribute to the risk of any disorder or disease. Psychiatric disorders can also be due to normal genes that are "on" that should be "off."
Mental health diagnoses contribute significantly
to the global burden of disease.
to appropriately prescribe psychotropic medications.
A strong understanding of the functions of the brain and neurotransmitter roles in illness and treatment is needed
Psychiatric prescribing decisions are based
on neuroscience and symptom presentation.
The field of epigenetics
is rapidly growing and can help explain how gene expression is influenced by environmental factors and how epigenetics contributes to the manifestation of mental illness.
when prescribing medications including
Consideration must also be given to each client's unique their symptoms, age, physical health, and lifestyle.
The potential legal and ethical issues impacting mental health treatment must
also be taken into account, including informed consent, competence to make healthcare decisions, and off-label prescribing.
Which of the following is a prominent CYP enzyme in the body and what is it responsible for?
CYP3A4 - responsible for metabolism of a number of medications
Dosing adjustments may be required.
What is the direct role of transcription factor?
influence gene expression
antagonist effect
antagonist effect - drug binds to receptor, but does not activate a response
Partial agonist
drug does not fully activate receptors
Inverse agonist -
drug causes opposite effect of the agonist.
Which is a first messenger?
neurotransmitter- G protein linked systems and ion channel linked cascades are triggered by neurotransmitters.
Which action explains an agonists effect on ligand-gated ion channels?
Agonists cause ligand-gated ion channels to open more frequently.
When prescribing psychotropic medications, the PMHNP knows that these medications work within which specific areas?
mood
dorsolateral prefrontal cortex (DLPFC)
is concerned with higher level functioning
VLPFC (ventrolateral prefrontal cortex)
involved with motor inhibition the IFG contains Broca's area which is associated with speech production understanding grammar.
Basal ganglia
are a group of structures involved in voluntary motor movements. Basal ganglia are also involved in cognition and emotion.
Psychosis
can be an overwhelming experience for clients, making them feel out of control and out of touch with reality.
Antipsychotic medications
can be effective in reducing the symptoms of psychosis.
Psychosis is a syndrome
that can be associated with several different psychiatric disorders.
Symptoms of psychosis include
hallucinations, delusions, disorganized speech, disorganized behavior, and distortions of reality.
This syndrome can affect a person's cognition, affective response, communication, capacity to recognize reality, and ability to relate to others
Psychosis
is a defining feature for some psychotic disorders while other disorders may have a psychotic component.
Psychosis is a defining
feature for some psychotic disorders while other disorders may have a psychotic component.
Diagnoses Requiring the Presence of Psychosis
schizophrenia
substance-induced psychotic disorders
schizophreniform disorder
schizoaffecive disorder
delusional disorder
brief psychotic disorder
psychotic disorder due to a medical condition
Diagnoses with Psychosis as a Feature
mania
depression
cognitive disorders
dementia
Schizophrenia
is one of the most common disorders treated by antipsychotic medications. The prevalence of schizophrenia is difficult to determine due to the complexity of the diagnosis and other factors.
Current estimates place the prevalence of schizophrenia and related psychotic disorders in the U.S. between 0.25% and 0.64% with international estimates of the prevalence of schizophrenia among non-institutionalized persons is 0.33% to 0.75%
Positive symptoms
H allucinations
D elusions
T hought disorder
H ostility
E xcitability
Motor symptoms
Motor delay
Dyscoordination
EPS, e.g.,ParkinsonismDyskinesia
Active symptoms
Depression
Anxiety
Suicidality
Cognition
Attention
Working memory
Verbal memory
Visual memory
Executive functioning
Processing speed
Social conditioning
Negative symptoms
Affective flattening
Alogia
Anhedonia
Amotivation
Asociality
Genetics
Many genes play a role in the likelihood that an individual will develop schizophrenia as do epigenetic factors. Heritability for schizophrenia may be as high as 79% .
Evidence exists that links gene-environment interaction to the diagnosis of schizophrenia
Environmental Triggers
Regular Cannabis Use
Exposure to Early Life
Trauma Sexual
Abuse Emotional
Abuse Emotional
Neglect
Bullying
Neuroanatomy
Several areas of the brain are associated with the symptoms of schizophrenia.
When brain circuitry in the prefrontal cortex malfunctions, patients may experience symptoms.
Mesocortical and ventromedial prefrontal cortex
negative and affective symptoms
Dorsolateral:
cognitive symptoms
Orbitofrontal and connections to the amygdala:
aggressive, impulsive symptoms
Dopamine Role in Psychosis
Many theories exist regarding the causes of psychosis and schizophrenia. A leading hypothesis is that psychosis and schizophrenia are associated with a dysfunction of the neurotransmitter dopamine (DA) (Stahl, 2021).
Dopamine dysfunctions are also involved in other conditions that cause psychosis, such as severe depression, certain medical disorders, and substance abuse.
Traditionally, schizophrenia and psychosis symptoms have been associated with a surplus of dopamine, since medications that block dopamine, specifically D2, have been found to reduce the positive symptoms of schizophrenia. Stahl (2021) suggests that it is more likely that schizophrenia symptoms are related to "out of tune" dopamine
Medications to treat psychosis are classified as either
first generation antipsychotics (FGAs) or second- generation antipsychotics (SGAs).
Antipsychotics are prescribed based on their pharmacological properties, side effect profiles, and adverse effects according to the unique symptoms and needs of individuals across the lifespan.
Within medication management, medications from this and other classes are used across many diagnoses, making the former naming conventions inaccurate.
Selecting medications based on mechanism of action allows for precise, individualized prescribing as specific symptoms are targeted.
First generation antipsychotics (FGAs) are also known as
typical antipsychotics and are appropriate for acute and chronic management of schizophrenia and psychosis.
First Generation Antipsychotics
Desirable Effects
Improves Positive Symptoms
Acute & Chronic Schizophrenia & Psychosis
Non-selectively blocks dopamine D2 receptors, specifically in mesolimbic pathway
Undesirable Effects
Risk of Developing
Hyperprolactinemia Desirable Effects
Improves Positive Symptoms
Acute & Chronic Schizophrenia & Psychosis
Non-selectively blocks dopamine D2 receptors, specifically in mesolimbic pathway
Undesirable Effects
Risk of Developing
Hyperprolactinemia
& Extrapyramidal Symptoms
(Negative Symptoms
Unaffected)